Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Betaxolol hydrochloride
Imbat Limited
S01ED; S01ED02
Betaxolol hydrochloride
0.5 Base %w/v
Eye drops, solution
Product subject to prescription which may be renewed (B)
Beta blocking agents1); betaxolol
Authorised
2011-11-04
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER BETOPTIC ® 0.5% W/V EYE DROPS, SOLUTION (Betaxolol (as hydrochloride)) Your medicine is available using the above name but will be referred to as Betoptic 0.5% throughout the leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE KEEP THIS LEAFLET. You may need to read it again. IF YOU HAVE ANY FURTHER QUESTIONS, ask your doctor or your pharmacist. This medicine has been prescribed for you. DO NOT PASS IT ON TO OTHERS. It may harm them, even if their symptoms are the same as yours. IF ANY OF THE SIDE EFFECTS GET SERIOUS, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1. WHAT BETOPTIC 0.5% IS AND WHAT IT IS USED FOR 2. BEFORE YOU USE BETOPTIC 0.5% 3. HOW TO USE BETOPTIC 0.5% 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE BETOPTIC 0.5% 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT BETOPTIC 0.5% IS AND WHAT IT IS USED FOR Betoptic 0.5% belongs to a group of medicines known as beta blockers. IT IS USED TO TREAT glaucoma or ocular hypertension (high pressure in the eye) by reducing the fluid pressure in your eye(s). 2. BEFORE YOU USE BETOPTIC 0.5% DO NOT USE BETOPTIC 0.5%... If you are ALLERGIC to betaxolol, beta-blockers or any of the other ingredients listed in section 6. Ask your doctor for advice. If you have now or have had in the past, RESPIRATORY PROBLEMS such as SEVERE ASTHMA, SEVERE CHRONIC OBSTRUCTIVE BRONCHITIS (severe lung condition which may cause wheeziness, difficulty in breathing and/or long-standing cough). If you have a SLOW HEART BEAT, HEART FAILURE, or DISORDERS OF HEART RHYTHM (IRREGULAR HEARTBEATS). TAKE SPECIAL CARE... Before you use this medicine, tell your doctor if you have now or have had in the past CORONARY HEART DISEASE (symptoms can include chest pain or tightness, breathlessness or choking), HEART FAILURE, LOW BLOOD PRESSURE (hypotension) DISTURBANCES OF HEART RATE such as slow heart beat (bradycardia Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Betoptic 0.5% w/v Eye Drops, Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Betaxolol 0.5% w/v (as hydrochloride). Excipients: Benzalkonium chloride 0.01% w/v. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution. _Product imported from: UK_ A clear, colourless to pale yellow, sterile eye drops solution. 4 CLINICAL PARTICULARS As per PA 0290/061/001 5 PHARMACOLOGICAL PROPERTIES As per PA 0290/061/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Disodium edetate Sodium chloride Benzalkonium chloride Sodium hydroxide (for pH-adjustment) Hydrochloric acid (for pH-adjustment) Purified water 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. After opening: 4 weeks. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _4_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _8_ _C_ _R_ _N_ _ _ _2_ _2_ _0_ _9_ _8_ _5_ _5_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 ° C. Store in the original package in order to protect from light. Discard remaining contents 4 weeks after first opening. 6.5 NATURE AND CONTENTS OF CONTAINER A plastic bottle with a screw cap containing 5ml of solution 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM Read the complete document